Sign In
Buy NVO
$47.42
+1.52 (+3.31%)
At Close: Jun 23, 2026
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
04:57pm, Thursday, 30'th Nov 2023
The lawsuits come as Novo Nordisk grapples with shortages of Wegovy and Ozempic in the U.S. due to skyrocketing demand.
Novo Nordisk Sues Two Florida Pharmacies For Allegedly Selling Impure Weight-Loss Drugs
09:59am, Thursday, 30'th Nov 2023
The Danish drugmaker claims one pharmacy is adding a banned substance to its drugs.
Novo Nordisk finds compounded Wegovy up to 33% impure, sues Florida pharmacies
06:21am, Thursday, 30'th Nov 2023
Novo Nordisk on Thursday said it sued one compounding pharmacy and refiled a lawsuit against another after finding their products claiming to contain the active ingredient for its in-demand weight-los
How to earn $500 a month from this stock?
07:32am, Wednesday, 29'th Nov 2023
Pfizer's (NASDAQ: PFE) stock continued its 11-month decline in November after its third-quarter sales missed expectations amid waning demand for Covid products.
Watch the buy range for Li Auto, MongoDB, Novo Nordisk
06:10am, Wednesday, 29'th Nov 2023
With the November rally in the SPDR S&P 500 ETF Trust NYSEARCA: SPY, a number of large-cap stocks are in buy range. Among those names are three large companies that are not S&P 500 components: Li Auto
Ozempic Receives Some Very Bad News: Is It Time to Sell Novo Nordisk Stock?
05:50am, Wednesday, 29'th Nov 2023
New real-world data show that Lilly's Mounjaro helped patients achieve significantly greater weight loss than Ozempic did. This demonstration of Mounjaro's efficacy could lead to a shift in prescribin
3 Large Drug Stocks That Have Outperformed Industry YTD
10:31am, Tuesday, 28'th Nov 2023
Eli Lilly (LLY), Novo Nordisk (NVO) and Novartis (NVS) have outperformed the industry this year.
Study finds Mounjaro outperforms Ozempic in overweight & obese adults: Truveta's VP of Research
06:27pm, Monday, 27'th Nov 2023
Dr. Nick Stucky, VP of Research at Truveta, joins 'Fast Money' to talk the results of a study comparing weight-loss drugs Mounjaro and Ozempic.
Mounjaro is more effective for weight loss than Ozempic: study reveals
12:22pm, Monday, 27'th Nov 2023
Mounjaro – a popular treatment for diabetes is more effective for losing weight than Ozempic, as per a large study of real-word data by Truveta Research.
Ozempic is not the most effective weight-loss drug on the market: study
11:05am, Monday, 27'th Nov 2023
Diabetes-turned-weight loss drug Mounjaro is more effective for shedding off extra pounds than its ultra-popular counterpart, Ozempic, according to a new study.
5 Must-Buy Stocks at 52-Week High With More Upside for 2024
09:47am, Monday, 27'th Nov 2023
We have narrowed our search to five large-cap stocks with more upside for 2024. These are: IT, PGR, CBOE, IHG, NVO.
4 Must-Buy Profitable Stocks Using Net Income Ratio
09:01am, Monday, 27'th Nov 2023
Lamb Weston (LW), e.l.f. Beauty (ELF), Novo Nordisk (NVO), and NVIDIA (NVDA) have been selected as the top picks with a high net income ratio.
Novo Nordisk: Massive Reality Check Awaits Greedy Investors
09:00am, Saturday, 25'th Nov 2023
Novo Nordisk's stock continues to surge as greedy investors exploit surging momentum, as they fear missing out on further potential gains. The company's impressive Q3 earnings results suggest the upwa
Could Ozempic Harm These 3 Medical Device Stocks?
06:58am, Saturday, 25'th Nov 2023
Ozempic could make some medical devices less necessary than before. If that happens, it would lead to lower revenue for the device makers.
Novo Nordisk: Healthy Gains Ahead, EPS Growth Seen, Technical Strength
01:43am, Saturday, 25'th Nov 2023
Novo Nordisk has surpassed Nestle as the largest developed-market stock outside of the US, indicating the success of the GLP-1 drug segment. The company had a strong Q3 with a 29% YoY increase in reve
